DGAP-Adhoc: NEXUS AG shows continued Growth and significant Increase in Profit in Q3-2011

NEXUS AG  / Key word(s): Quarter Results

07.11.2011 08:01

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Villingen-Schwenningen, 7 November 2011: NEXUS AG, Villingen Schwenningen,
listed in Prime Standard, improved its sales to KEUR 38,436 in the first
nine months 2011 from KEUR 32,160 (+ 19.5 %) and achieved a substantially
better result before taxes of KEUR 3,573 compaed to KEUR 2,476 in the
previous year (+ 44.3%).

The EBIT was KEUR 3,369 to KEUR 2,331 (+ 44.5%) compared to the previous
year. The EBITDA improved from KEUR 6,468 to KEUR 7,829 (+ 21.0%) while the
result after tax increased by 44.6% from KEUR 3,630 to KEUR 2,510.

Sales in the core business, Healthcare Software, increased by 22.8 % to
KEUR 35,332 (previous year: KEUR 28,782) in the first nine months. The
Healthcare Service Division closed KEUR 3,104 after KEUR 3,378 about 8 %
under the previous year's value.

In the third quarter, sales of KEUR 13,892 were recorded following KEUR
11,429 in the previous year (+ 21.6%). The result befor tax in the third
quarter is KEUR 914 and is about 2% higher than the value of the previous
year (Q3-2010: KEUR 899).

The operative cash flow of KEUR 8,662 is approx. 17.6% higher than the
previous years level (previous year: KEUR 7,363). The foreign share of
Group sales was about 43.5% in the first nine months to 37.9% in the
previous year.

Due to the positive earnings the cash reserves and securities increased
significantly to 21.572 million EUR. NEXUS AG had equity capital of approx.
EUR 57.2 million on 30 September 2011. The group has not any essential
financial liabilities and the equity capital rate is 74 % of the balance
sheet.


NEXUS - the eHealth specialist - develops and sells modular software
solutions internationally for healthcare systems in the areas of 'Clinical
Information Systems' (CIS), 'Diagnostic Information Systems' (DIS) and 'IT
Services'.
Comprehensive solutions for hospitals and psychiatric institutions are
designed and supported within NEXUS / CIS. The solutions of NEXUS / DIS
cover special ward and specialist areas for radiology, pathology as well as
for gynecology/obstetrics and intensive care medicine. NEXUS bets on
modern, modular software architecture in all product areas, which enables
flexible and stepby-step introduction of NEXUS systems.
More than 450 staff members in the NEXUS Group develop software solutions
for the healthcare sector, with which approximately 110,000 users in 23
countries work.



Additional information:

NEXUS AG
Mr. Simon Holzer

Tel.: +49 (0) 77 21/84 82 0
Fax: +49 (0) 77 21/84 82 888
ir@nexus-ag.de 
www.nexus-ag.de. 




07.11.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      NEXUS AG
              Auf der Steig 6
              78052 Villingen-Schwenningen
              Germany
Phone:        +49 (0)7721 8482-0
Fax:          +49 (0)7721 8482-888
E-mail:       mail@nexus-ag.de
Internet:     www.nexus-ag.de
ISIN:         DE0005220909
WKN:          522090
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, München, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------